CN104370866A - Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride - Google Patents

Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride Download PDF

Info

Publication number
CN104370866A
CN104370866A CN201410704857.1A CN201410704857A CN104370866A CN 104370866 A CN104370866 A CN 104370866A CN 201410704857 A CN201410704857 A CN 201410704857A CN 104370866 A CN104370866 A CN 104370866A
Authority
CN
China
Prior art keywords
product
dimethoxy
suction filtration
certain amount
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410704857.1A
Other languages
Chinese (zh)
Inventor
李卓才
李苏杨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Jonathan New Materials Technology Co Ltd
Original Assignee
Suzhou Jonathan New Materials Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Jonathan New Materials Technology Co Ltd filed Critical Suzhou Jonathan New Materials Technology Co Ltd
Priority to CN201410704857.1A priority Critical patent/CN104370866A/en
Publication of CN104370866A publication Critical patent/CN104370866A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention discloses a synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride. The method includes the steps of a, synthesizing (4, 6-dimethoxy-3-trichloromethyl)-2-benzo[c]furanone (I); b, synthesizing (4, 6-dimethoxy)-2-benzo[c]furanone-3-carboxylic acid (II); c, synthesizing (4, 6-dimethoxy)-2-benzo[c]furanone (III); d, synthesizing 3, 5-dimethoxy-phthalic acid (IV); and e, synthesizing 3, 5-dimethoxy-phthalic anhydride.

Description

The synthetic method of medicinal intermediate 3,5-dimethoxy-phthalic anhydride
Technical field
The invention belongs to chemical field, relate to the preparation method of pharmaceutical intermediate, be specifically related to the synthetic method of 3,5-dimethoxy-Tetra hydro Phthalic anhydride.
Background technology
3,5-dimethoxy-Tetra hydro Phthalic anhydride is the important intermediate of the medicines such as synthesis hypericin, Schuttgelb, emodin monoglucoside.Prove according to the study, the medicines such as hypericin have good physiologically active, and using value is very high, especially in anti AIDS virus, have significant curative effect.But because hypericin content in natural phant is very micro-, far can not meet needs that are clinical and fundamental research, be worth and have multiple unfavorable factor by the Chinese medicine of artificial culture.Therefore, the chemosynthesis approach seeking a kind of 3,5-dimethoxy-Tetra hydro Phthalic anhydride is extremely important.
Summary of the invention
Given this, the object of the invention is the synthetic method providing a kind of 3,5-dimethoxy-Tetra hydro Phthalic anhydride.
For solving above technical problem, technical scheme provided by the invention is, provides a kind of synthetic method of medicinal intermediate 3,5-dimethoxy-phthalic anhydride, comprises the following steps:
A) synthesis of (4,6-dimethoxy-3-trichloromethyl)-2-benzo [c] furanone (I)
First get a certain amount of 3,5-dimethoxy p-methyls and Chloral Hydrate adds in four-necked bottle, then prepare the sulfuric acid of 90%, without the need to cooling, add in four-necked bottle, react beginning with vigorous stirring, after controlling the continuous mechanical stirring 24h of temperature of reaction, reaction terminates; Pour out product to stir in a certain amount of water, suction filtration, then use the hot methanol washing leaching cake several of 50%, remove responseless raw material; Desciccate, weighs, and leaves and takes a certain amount of product and detects; Product I is white crystal, fusing point 125-127 DEG C;
B) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid (II)
Get 60g product I, add in four-necked bottle, slowly added in reactor by the 305mL16.8% sodium hydroxide solution prepared, stir, slowly heating up makes temperature control at 80-90 DEG C; After reaction 3h, solution is by colourless to being finally tawny, and reaction terminates; Stop heating, cooling, suction filtration; Add diluted acid in filtrate, acidifying, leave standstill; Isolate white precipitate product II, i.e. (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid;
C) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone (III)
Get 30g product II to add in three-necked bottle, and the dimethyl phthalate adding 75mL makes solvent, stir, heating, maintains the temperature at 180-185 DEG C, till when being heated to release without gas; Place cooling, mass sets; Add a certain amount of methanol solution, stir, a part of dissolution of solid; Solution suction filtration, filter cake ether washes 3 times, dry cake, obtains product as light yellow solid III;
The synthesis of d) 3,5-dimethoxys-phthalic acid (IV)
The product III getting 20g adds in there-necked flask, at room temperature slowly adds the basic solution of a certain amount of 3% potassium permanganate, and stir time enough, until potassium permanganate no longer fades, oxidizing reaction is complete; Heated mixt to 50 DEG C, and adds a certain amount of ethanol decolorization, removes excessive potassium permanganate, and steams excessive ethanol and a part of water; Suction filtration, filtrate uses acidifying, adularescent Precipitation, and leave standstill, suction filtration, dry cake, obtains white solid product IV;
The synthesis of e) 3,5-dimethoxys-Tetra hydro Phthalic anhydride is got
The product IV of 9g and the diacetyl oxide of 36g add in four-necked bottle, and after reflux 2h, reaction is substantially complete, will crystallize out by some pure acid anhydrides, suction filtration after cooling mixture; After filtrate decompression distillation all steams acetic acid, and cool, obtain the pure crystalline of part in addition, crystallization benzene and sherwood oil recrystallization, namely obtain final product 3,5 one dimethoxy one Tetra hydro Phthalic anhydrides.
Compared with prior art, a technical scheme tool in technique scheme has the following advantages:
5 step reactions of the present invention complete all at ambient pressure, and other required mild condition, does not have harsh reaction conditions, and easy and simple to handle, without the need to loaded down with trivial details last handling process, and all recyclable recycling of byproduct of gained; The good product purity of reaction gained, the yield of the finished product is high.Target product is met by the product of the analysis means such as differential thermal analysis, infrared, mass spectrum, nuclear-magnetism qualification gained.Synthesized 3,5-dimethoxys-Tetra hydro Phthalic anhydride has great importance for medicines such as semi-synthetic hypericin, Schuttgelb, emodin monoglucosides.
Embodiment
In the present embodiment, the synthetic method of medicinal intermediate 3,5-dimethoxy-phthalic anhydride, step is as follows:
A) synthesis of (4,6-dimethoxy-3-trichloromethyl)-2-benzo [c] furanone (I)
First get a certain amount of 3,5-dimethoxy p-methyls and Chloral Hydrate adds in four-necked bottle, then prepare the sulfuric acid of 90%, without the need to cooling, add in four-necked bottle, react beginning with vigorous stirring, after reaction 20min, start to occur colour-change, and find that there is suspended substance appearance; Thin-layer chromatographic analysis is made in sampling, and compares with the thin-layer chromatographic analysis of raw material, finds that reaction starts to produce new material, and after controlling the continuous mechanical stirring 24h of temperature of reaction, reaction terminates substantially, does tlc analysis and finds that raw material point disappears; Pour out product to stir in a certain amount of water, suction filtration, then use the hot methanol washing leaching cake several of 50%, remove responseless raw material; Desciccate, weighs, and leaves and takes a certain amount of product and detects; Product is white crystal, fusing point 125-127 DEG C; B) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid (II)
Get 60g (0.1926mol) product I, add in four-necked bottle, slowly added in reactor by the 305mL sodium hydroxide solution (16.8%) prepared, stir, slowly heating up makes temperature control at 80-90 DEG C; After reaction 3h, solution is by colourless to being finally tawny, and reaction terminates; Stop heating, cooling, suction filtration; Add diluted acid in filtrate, acidifying, leave standstill; Isolate white precipitate, i.e. (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid; Suction filtration, dry, weigh to obtain 45g, and productive rate can reach 100%, and fusing point is 188.57-191.37 DEG C;
C) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone (III)
Get 30g (0.1261mol) product II to add in three-necked bottle, and the dimethyl phthalate adding 75mL makes solvent, stir, heating, maintains the temperature at 180-185 DEG C, and reaction 0.5h can find solid melts, there is gas to produce, till when being heated to release without gas simultaneously; Place cooling, mass sets; Add a certain amount of methanol solution, stir, a part of dissolution of solid; Solution suction filtration, filter cake ether washes 3 times, dry cake, weighs and obtains 23g light yellow solid, and yield can reach 96%, and fusing point is 169.23-170.48 DEG C;
The synthesis of d) 3,5-dimethoxys-phthalic acid (IV)
The product III getting 20g (0.1031mol) adds in there-necked flask, at room temperature slowly adds the basic solution of a certain amount of 3% potassium permanganate, and stir time enough, until potassium permanganate no longer fades, oxidizing reaction is complete; Heated mixt to 50 DEG C, and adds a certain amount of ethanol decolorization, removes excessive potassium permanganate, and steams excessive ethanol and a part of water; Suction filtration, filtrate uses acidifying, adularescent Precipitation, leaves standstill, suction filtration, dry cake, and weigh and obtain 21.5g (0.0951mol) white solid, yield is 93%;
The synthesis of e) 3,5-dimethoxys-Tetra hydro Phthalic anhydride is got
The product IV of 9g (0.038mol) and the diacetyl oxide of 36g (0.3529mo1) add in four-necked bottle, and after reflux 2h, reaction is substantially complete, will crystallize out by some pure acid anhydrides, suction filtration after cooling mixture; After filtrate decompression distillation all steams acetic acid, and cool, obtain the pure crystalline of part in addition, crystallization benzene and sherwood oil recrystallization, namely obtain final product 3,5 one dimethoxy one Tetra hydro Phthalic anhydrides; Weigh to obtain 7.55g (0.03630mol) White Flocculus, yield reaches 91.2%.
Below be only the preferred embodiment of the present invention, it should be pointed out that above-mentioned preferred implementation should not be considered as limitation of the present invention, protection scope of the present invention should be as the criterion with claim limited range.For those skilled in the art, without departing from the spirit and scope of the present invention, can also make some improvements and modifications, these improvements and modifications also should be considered as protection scope of the present invention.

Claims (1)

1. a synthetic method for medicinal intermediate 3,5-dimethoxy-phthalic anhydride, is characterized in that, comprises the following steps: a) synthesis of (4,6-dimethoxy-3-trichloromethyl)-2-benzo [c] furanone (I)
First get a certain amount of 3,5-dimethoxy p-methyls and Chloral Hydrate adds in four-necked bottle, then prepare the sulfuric acid of 90%, without the need to cooling, add in four-necked bottle, react beginning with vigorous stirring, after controlling the continuous mechanical stirring 24h of temperature of reaction, reaction terminates; Pour out product to stir in a certain amount of water, suction filtration, then use the hot methanol washing leaching cake several of 50%, remove responseless raw material; Desciccate, weighs, and leaves and takes a certain amount of product and detects; Product I is white crystal, fusing point 125-127 DEG C;
B) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid (II)
Get 60g product I, add in four-necked bottle, slowly added in reactor by the 305mL16.8% sodium hydroxide solution prepared, stir, slowly heating up makes temperature control at 80-90 DEG C; After reaction 3h, solution is by colourless to being finally tawny, and reaction terminates; Stop heating, cooling, suction filtration; Add diluted acid in filtrate, acidifying, leave standstill; Isolate white precipitate product II, i.e. (4,6-dimethoxy)-2-benzo [c] furanone-3-carboxylic acid;
C) synthesis of (4,6-dimethoxy)-2-benzo [c] furanone (III)
Get 30g product II to add in three-necked bottle, and the dimethyl phthalate adding 75mL makes solvent, stir, heating, maintains the temperature at 180-185 DEG C, till when being heated to release without gas; Place cooling, mass sets; Add a certain amount of methanol solution, stir, a part of dissolution of solid; Solution suction filtration, filter cake ether washes 3 times, dry cake, obtains product as light yellow solid III;
The synthesis of d) 3,5-dimethoxys-phthalic acid (IV)
The product III getting 20g adds in there-necked flask, at room temperature slowly adds the basic solution of a certain amount of 3% potassium permanganate, and stir time enough, until potassium permanganate no longer fades, oxidizing reaction is complete; Heated mixt to 50 DEG C, and adds a certain amount of ethanol decolorization, removes excessive potassium permanganate, and steams excessive ethanol and a part of water; Suction filtration, filtrate uses acidifying, adularescent Precipitation, and leave standstill, suction filtration, dry cake, obtains white solid product IV;
The synthesis of e) 3,5-dimethoxys-Tetra hydro Phthalic anhydride
The product IV of 9g and the diacetyl oxide of 36g add in four-necked bottle, and after reflux 2h, reaction is substantially complete, will crystallize out by some pure acid anhydrides, suction filtration after cooling mixture; After filtrate decompression distillation all steams acetic acid, and cool, obtain the pure crystalline of part in addition, crystallization benzene and sherwood oil recrystallization, namely obtain final product 3,5 one dimethoxy one Tetra hydro Phthalic anhydrides.
CN201410704857.1A 2014-11-27 2014-11-27 Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride Pending CN104370866A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410704857.1A CN104370866A (en) 2014-11-27 2014-11-27 Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410704857.1A CN104370866A (en) 2014-11-27 2014-11-27 Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride

Publications (1)

Publication Number Publication Date
CN104370866A true CN104370866A (en) 2015-02-25

Family

ID=52550101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410704857.1A Pending CN104370866A (en) 2014-11-27 2014-11-27 Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride

Country Status (1)

Country Link
CN (1) CN104370866A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857861A (en) * 1970-09-07 1974-12-31 Oreal Process for the preparation of di-lower alkoxy-3,5-phthalic anhydrides
CN103086947A (en) * 2011-11-04 2013-05-08 赵庆春 Phthalimide compounds with antiangiogenic activity and purpose thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857861A (en) * 1970-09-07 1974-12-31 Oreal Process for the preparation of di-lower alkoxy-3,5-phthalic anhydrides
CN103086947A (en) * 2011-11-04 2013-05-08 赵庆春 Phthalimide compounds with antiangiogenic activity and purpose thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
孙小莉 等: "药物中间体3,5-二甲氧基-邻苯二甲酸酐的合成及表征", 《应用化工》 *
孙小莉: "金丝桃素的全合成研究——中间体3,5-二甲氧基—邻苯二甲酸酐的合成", 《南京理工大学硕士研究生学位论文》 *
杜杨 等: "3,5-二甲氧基邻苯二甲酸酐的合成与表征", 《精细化工》 *

Similar Documents

Publication Publication Date Title
CN101104583B (en) Technique for preparing diacerein by two-step oxidation process
CN102395591B (en) Method for preparing prasugrel
CN103848783B (en) The method of the synthetic 2-chlorine apellagrin of a kind of oxidation step
CN103121887B (en) The preparation method of 1,3-indenes cyclohexadione compounds
CN104844593A (en) Synthetic method for Apixaban drug intermediate
CN115403577B (en) Synthesis method of carboxyl azaindole
CN104370866A (en) Synthetic method of drug intermediate 3, 5-dimethoxy-phthalic anhydride
CN101270124B (en) Novel method for purifying and preparing high-purity fluorandiol and fluorandiol salt
CN109369492A (en) The preparation method of one kind (1S, 4S) -2-Boc-2,5- diaza-bicyclo [2.2.1] heptane
CN101805288A (en) Novel method for synthesizing cloquintocet-mexyl
CN105330545A (en) Method for recycling oxalic acid from triazine ring cyclization mother liquor dreg with tin chloride as catalyst
TWI555727B (en) A method of making vitamin k1
CN107936045A (en) A kind of preparation method of high-purity Flurbiprofen known impurities
CN106831648B (en) The synthetic method of diazoxiide
CN108129531A (en) A kind of preparation method of hesperidin methyl
CN107879979A (en) A kind of preparation method of Dexmedetomidine
CN105130972B (en) Benzoic acid emtricitabine salt, its preparation method and the method for preparing emtricitabine with benzoic acid emtricitabine salt
CN110938106B (en) Method for preparing obeticholic acid intermediate and obeticholic acid thereof
CN107325078B (en) Preparation method of cilostazol
CN109694311B (en) Method for synthesizing isoliquiritigenin
CN109134351B (en) Synthesis method of S-3- (4-aminophenyl) piperidine
CN106749098A (en) A kind of friendly process for preparing dioxopromethazine hydrochloride as oxidant with oxygen
CN105801482A (en) Method for preparing 1-cyclopropyl-4-oxo-7-bromine-8-difluoromethoxy-1,4-dihydro-quinoline-3-nonanoic acid-ethyl ester
CN107056691B (en) Method for preparing etoricoxib crystal form V
CN103772282B (en) A kind of preparation method of the 3-tertiary butyl-1H-pyrazoles-4-formaldehyde

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150225